(heparin[mesh] OR dihydroergotamine[mesh] OR drug combinations[mesh] OR heparin, low-molecular-weight[mesh] OR taurocholic acid[mesh] OR deoxycholic acid[mesh] OR chondroitin sulfates[mesh] OR dermatan sulfate[mesh] OR heparitin sulfate[mesh] OR nadroparin[mesh] OR enoxaparin[mesh] OR dalteparin[mesh] OR tinzaparin[mesh] OR Heparin[Text Word] OR (LMWH[Text Word] OR low molecular weight heparin[Text Word] OR nadroparin[Text Word] OR fraxiparin[Text Word] OR enoxaparin[Text Word] OR clexane[Text Word] OR lovenox[Text Word] OR dalteparin[Text Word] OR fragmin[Text Word] OR ardeparin[Text Word] OR normiflo[Text Word] OR tinzaparin[Text Word] OR logiparin[Text Word] OR innohep[Text Word] OR certoparin[Text Word] OR sandoparin[Text Word] OR reviparin[Text Word] OR clivarin[Text Word] OR danaproid[Text Word] OR orgaran[Text Word])) AND (neoplasms[mesh] OR carcinoma[mesh] OR adenocarcinoma[mesh] OR biomarkers, tumor[mesh] OR malignan*[Text Word] OR neoplasm*[Text Word] OR cancer[Text Word] OR carcinoma*[Text Word] OR adenocarcinoma[Text Word] OR tumor[Text Word] OR tumor[Text Word]) AND (warfarin[mesh] OR drug resistance[mesh] OR metabolism, inborn errors[mesh] OR acenocoumarol[mesh] OR leukemia, lymphocytic, chronic, b-cell[mesh] OR vitamin k[mesh] OR warfarin[Text Word] OR coumadin[Text Word] OR acenocumarol[Text Word] OR phenprocumon[Text Word] OR 4-hydroxicoumarins[Text Word] OR oral anticoagulant[Text Word] OR vitamin K antagonist[Text Word] OR VKA[Text Word])